Detailed information for compound 282872

Basic information

Technical information
  • TDR Targets ID: 282872
  • Name: (2S)-1-[(2R)-2-(benzylsulfonylamino)-3-cycloh exylpropanoyl]-N-(4,5,6,7-tetrahydro-1H-indaz ol-5-ylmethyl)pyrrolidine-2-carboxamide
  • MW: 555.732 | Formula: C29H41N5O4S
  • H donors: 3 H acceptors: 5 LogP: 4.28 Rotable bonds: 12
    Rule of 5 violations (Lipinski): 2
  • SMILES: O=C([C@@H]1CCCN1C(=O)[C@H](NS(=O)(=O)Cc1ccccc1)CC1CCCCC1)NCC1CCc2c(C1)c[nH]n2
  • InChi: 1S/C29H41N5O4S/c35-28(30-18-23-13-14-25-24(16-23)19-31-32-25)27-12-7-15-34(27)29(36)26(17-21-8-3-1-4-9-21)33-39(37,38)20-22-10-5-2-6-11-22/h2,5-6,10-11,19,21,23,26-27,33H,1,3-4,7-9,12-18,20H2,(H,30,35)(H,31,32)/t23?,26-,27+/m1/s1
  • InChiKey: XZSAVYJAPIZAPG-VNCAGCHFSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • (2S)-1-[(2R)-2-(benzylsulfonylamino)-3-cyclohexyl-propanoyl]-N-(4,5,6,7-tetrahydro-1H-indazol-5-ylmethyl)pyrrolidine-2-carboxamide
  • (2S)-1-[(2R)-2-(benzylsulfonylamino)-3-cyclohexyl-1-oxopropyl]-N-(4,5,6,7-tetrahydro-1H-indazol-5-ylmethyl)-2-pyrrolidinecarboxamide
  • (2S)-1-[(2R)-3-cyclohexyl-2-(phenylmethylsulfonylamino)propanoyl]-N-(4,5,6,7-tetrahydro-1H-indazol-5-ylmethyl)pyrrolidine-2-carboxamide
  • (2S)-1-[(2R)-3-cyclohexyl-1-oxo-2-(phenylmethylsulfonylamino)propyl]-N-(4,5,6,7-tetrahydro-1H-indazol-5-ylmethyl)-2-pyrrolidinecarboxamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens coagulation factor II (thrombin) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) blistered cuticle protein 3 0.0468 1 1
Loa Loa (eye worm) hypothetical protein 0.0468 1 1
Brugia malayi Animal haem peroxidase family protein 0.0468 1 1
Onchocerca volvulus Chorion peroxidase homolog 0.0468 1 1
Loa Loa (eye worm) hypothetical protein 0.0468 1 1
Loa Loa (eye worm) hypothetical protein 0.0468 1 1
Loa Loa (eye worm) animal heme peroxidase 0.0468 1 1
Onchocerca volvulus Peroxidasin homolog 0.0468 1 1
Brugia malayi Animal haem peroxidase family protein 0.0468 1 1
Toxoplasma gondii EGF family domain-containing protein 0.0151 0 0.5
Loa Loa (eye worm) animal heme peroxidase 0.0468 1 1
Loa Loa (eye worm) hypothetical protein 0.0468 1 1
Loa Loa (eye worm) hypothetical protein 0.0468 1 1
Brugia malayi Animal haem peroxidase family protein 0.0468 1 1
Brugia malayi Animal haem peroxidase family protein 0.0468 1 1
Brugia malayi Peroxidasin 0.0468 1 1
Brugia malayi Blistered cuticle protein 3 0.0468 1 1
Loa Loa (eye worm) hypothetical protein 0.0468 1 1
Onchocerca volvulus Peroxidase homolog 0.0468 1 1
Loa Loa (eye worm) hypothetical protein 0.0468 1 1
Onchocerca volvulus Dual oxidase homolog 0.0468 1 1
Echinococcus multilocularis peroxidasin 0.0468 1 1
Loa Loa (eye worm) hypothetical protein 0.0468 1 1
Onchocerca volvulus Peroxidase homolog 0.0468 1 1
Loa Loa (eye worm) hypothetical protein 0.0468 1 1
Giardia lamblia High cysteine protein 0.0151 0 0.5
Loa Loa (eye worm) animal heme peroxidase 0.0468 1 1
Brugia malayi Animal haem peroxidase family protein 0.0468 1 1
Onchocerca volvulus 0.0468 1 1
Schistosoma mansoni peroxidasin 0.0468 1 1
Loa Loa (eye worm) hypothetical protein 0.0468 1 1
Loa Loa (eye worm) hypothetical protein 0.0468 1 1
Loa Loa (eye worm) animal heme peroxidase 0.0468 1 1
Schistosoma mansoni peroxidasin 0.0468 1 1
Loa Loa (eye worm) hypothetical protein 0.0468 1 1
Onchocerca volvulus Peroxidasin homolog 0.0468 1 1
Loa Loa (eye worm) hypothetical protein 0.0468 1 1
Echinococcus granulosus peroxidasin 0.0468 1 1
Loa Loa (eye worm) hypothetical protein 0.0468 1 1
Onchocerca volvulus 0.0468 1 1
Onchocerca volvulus 0.0468 1 1

Activities

Activity type Activity value Assay description Source Reference
Concentration (functional) = 11 uM Concentration of the compound required to double the thrombin time in human plasma (TT) ChEMBL. 12617892
Concentration (functional) = 42.3 uM Concentration of the compound required to double the activated partial thromboplastin time in human plasma (APTT) ChEMBL. 12617892
Concentration (functional) = 78.3 uM Concentration of the compound required to double the activated prothrombin time in human plasma (PT) ChEMBL. 12617892
Ki (binding) = 0.14 uM In vitro inhibitory activity against Thrombin ChEMBL. 12617892
Ki (binding) = 0.14 uM In vitro inhibitory activity against Thrombin ChEMBL. 12617892
Ki (binding) > 68.3 uM In vitro inhibitory activity against Trypsin ChEMBL. 12617892
Ki (binding) > 68.3 uM In vitro inhibitory activity against Trypsin ChEMBL. 12617892
Ki (binding) > 75.4 uM In vitro inhibitory activity of the compound against Factor Xa ChEMBL. 12617892
Ki (binding) > 75.4 uM In vitro inhibitory activity of the compound against Factor Xa ChEMBL. 12617892
Ratio (binding) > 478 Selectivity ratio of thrombin to trypsin ChEMBL. 12617892

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.